6533b871fe1ef96bd12d1584

RESEARCH PRODUCT

ADIPONECTIN, LEPTIN AND MMP-3 PLASMATIC LEVELS CANNOT IDENTIFY HIGH-RISK PROSTATE CANCER IN PATIENTS UNDERGOING BIOPSY

S SiracusanoAlberto AbrateF Di MaidaN GiacaloneA CangemiM MoschiniR ColomboAlchiede SimonatoVincenzo Serretta

subject

prostate cancer adiponenctin Leptin MMP-3 metabolic syndromehttp://hdl.handle.net/10447/210185